Abstract
Behçet’s disease (BD) can involve any site of the alimentary canal, yet the entire digestive tract has not been studied extensively. This cross-sectional observational study included 1,232 consecutive BD patients who underwent endoscopy. We found that 22.16% (273/1232) of H. pylori-negative BD patients had gastrointestinal ulcers. Notably, 61.54% of these patients were asymptomatic. Ulcers were found in various segments, with isolated upper gastrointestinal involvement occurring in 84 patients. Inflammation was the most common histopathologic feature (77.60%). High CRP levels and fever were identified as risk factors for gastrointestinal involvement, while uveitis appeared to be a protective factor. Routine endoscopy is recommended for BD patients, particularly those with systemic inflammatory markers.
Introduction
Behçet’s Disease is a chronic inflammatory disorder characterized by systemic vasculitis. While its hallmark symptoms include oral and genital ulcers, gastrointestinal (GI) involvement—often termed "entero-BD"—presents significant clinical risks, including perforation and hemorrhage. Historically, research has focused on the ileocecal region. However, the prevalence and characteristics of ulcers across the entire digestive tract, including the esophagus and stomach, remain under-documented. This study aims to describe the prevalence, location, and clinical features of GI ulcers in a large cohort of BD patients.
Methods
Researchers at Huadong Hospital, Fudan University, conducted a cross-sectional study of 1,232 consecutive BD patients between 2013 and 2020. All patients met the 2013 International Criteria for Behçet’s Disease (ICBD). Endoscopic screenings (upper and/or lower) were performed based on patient preference. To isolate BD-specific manifestations, patients with H. pylori infections, tuberculosis, or NSAID-related ulcers were excluded. Multivariate logistic regression was employed to identify independent predictors for GI involvement.
Results
Prevalence and Asymptomatic Presentation
Of the 1,232 patients screened, 273 (22.16%) were confirmed to have GI ulcers. A striking finding was the lack of clinical symptoms in the majority of these cases; 61.54% of patients with confirmed ulcers were asymptomatic at presentation.
Distribution and Clinical Features
While the ileocecal region was the most frequent site of involvement (106 cases), isolated upper GI ulcers were significant, occurring in 84 patients. The study compared patients with isolated upper GI ulcers to those with isolated ileocecal ulcers, finding significant differences in age at onset and certain clinical manifestations like skin and neurologic lesions.
Risk and Protective Factors
Multivariate analysis identified fever (OR = 0.235, P = 0.001) and high CRP levels (OR = 0.991, P = 0.019) as strong predictors of internal GI involvement. Conversely, uveitis (eye inflammation) was identified as a protective factor (OR = 2.480, P = 0.002), suggesting distinct disease phenotypes where BD may primarily target either the eyes or the gut.
Discussion
The high rate of asymptomatic ulcers suggests that relying solely on patient-reported symptoms is insufficient for managing BD. The presence of systemic inflammatory markers like fever and elevated CRP should serve as "red flags" for clinicians to perform endoscopic evaluations.
The study's limitations include its single-center design and the inherent difficulty of capturing deep-seated vasculitis through superficial endoscopic biopsies. Future research should investigate the biological mechanisms behind the divergent ocular and gastrointestinal phenotypes observed in this cohort.
Conclusion
BD can affect the upper gastrointestinal tract independently and often silently. Routine endoscopy should be considered for all BD patients, especially those presenting with fever and high CRP, to prevent severe complications like perforation or bleeding.
Summary updated